Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY-NC-ND 4.0International Journal of Oncology

Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)

  • Lijuan Wang1
  • Chenjin Ruan2
  1. 1Department of Respiratory and Critical Care Medicine, Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China
  2. 2Department of Thoracic Surgery, Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, P.R. China
Read full textDOICite

Abstract

Lung adenocarcinoma (LUAD) represents the most prevalent type of lung cancer, accounting for 35-40% of all lung cancer cases. Regulatory T cells (Tregs), a CD4+ T cell subtype with immunosuppressive functions, play a pivotal role in maintaining self-tolerance under physiological conditions. Recent evidence has increasingly highlighted their involvement in various cancers. In LUAD, Treg infiltration into tissues undermines the immune anticancer response, correlating with disease stage, treatment efficacy and prognosis. By inhibiting robust anti-tumor immune mechanisms, Tregs facilitate tumor immune escape in LUAD. Furthermore, elevated Treg cell accumulation in LUAD has been linked to reduced overall survival rates. Tregs serve as independent predictors for LUAD diagnosis in patients at high risk of recurrence. Systematic depletion of all Tregs to enhance anticancer efficacy poses risks of inducing severe autoimmune pathologies. Consequently, understanding the precise structure of tumor-infiltrating Tregs is essential for effective targeting of these cells in tumors. Additionally, identifying candidate targets or methods for the specific elimination of tumor-infiltrating Tregs is necessary for developing efficient and safe combination immunotherapy strategies for LUAD. The present study focuses on the regulatory role of Tregs in LUAD prognosis, immune escape and targeted therapies, elucidating the molecular mechanisms of Treg involvement and presenting associated therapeutic targets.

Related

  1. Tumor microenvironment-driven immune evasion in triple-negative breast cancer: mechanisms, clinical challenges, and therapeutic opportunities
    Hui Zhang, Kun Zhou, Na Li +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  2. Engineered bacteria-mediated stromal remodeling in pancreatic ductal adenocarcinoma: therapeutic opportunities and translational limits-a narrative review.
    Tao Wang, Xinying Zhu, Xingyu Li +2
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textSystems & synthetic biologyEurope PMC
  3. Stem cell factor in allergic diseases: mechanisms of type 2 immunity and therapeutic opportunities
    Ramon Ocadiz-Ruiz, Sarita Montaño, Nicholas W. Lukacs +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  4. Itaconate as an immunometabolic hub in host-pathogen interactions: Mechanisms, resistance, and therapeutic opportunities.
    Wei Zuo, Xinhui Wang, Jiaxiang Sun +9
    VirulencePeer-reviewedCC BYFull textImmunologyEurope PMC
  5. STAT3 at the tumor-immune interface: mechanisms of immune escape and therapeutic opportunities
    Xuanya Cheng, Haoren Jing, Mingqing Zhang
    Frontiers in ImmunologyPeer-reviewedCC BY5 citedImmunologyOpenAlex

Cite

BibTeXRIS
BibTeX
@article{wang2026regulatory,
  title = {{Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)}},
  author = {Lijuan Wang and Chenjin Ruan},
  journal = {International Journal of Oncology},
  year = {2026},
  month = oct,
  doi = {10.3892/ijo.2026.5943},
  url = {https://doi.org/10.3892/ijo.2026.5943},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)
AU  - Lijuan Wang
AU  - Chenjin Ruan
PY  - 2026
DA  - 2026/10/06
JO  - International Journal of Oncology
DO  - 10.3892/ijo.2026.5943
UR  - https://doi.org/10.3892/ijo.2026.5943
AB  - Lung adenocarcinoma (LUAD) represents the most prevalent type of lung cancer, accounting for 35-40% of all lung cancer cases. Regulatory T cells (Tregs), a CD4+ T cell subtype with immunosuppressive functions, play a pivotal role in maintaining self-tolerance under physiological conditions. Recent evidence has increasingly highlighted their involvement in various cancers. In LUAD, Treg infiltration into tissues undermines the immune anticancer response, correlating with disease stage, treatment efficacy and prognosis. By inhibiting robust anti-tumor immune mechanisms, Tregs facilitate tumor immune escape in LUAD. Furthermore, elevated Treg cell accumulation in LUAD has been linked to reduced overall survival rates. Tregs serve as independent predictors for LUAD diagnosis in patients at high risk of recurrence. Systematic depletion of all Tregs to enhance anticancer efficacy poses risks of inducing severe autoimmune pathologies. Consequently, understanding the precise structure of tumor-infiltrating Tregs is essential for effective targeting of these cells in tumors. Additionally, identifying candidate targets or methods for the specific elimination of tumor-infiltrating Tregs is necessary for developing efficient and safe combination immunotherapy strategies for LUAD. The present study focuses on the regulatory role of Tregs in LUAD prognosis, immune escape and targeted therapies, elucidating the molecular mechanisms of Treg involvement and presenting associated therapeutic targets.
SN  - 1019-6439
SN  - 1791-2423
ER  -